Reperfusion of specific brain regions by raising blood pressure restores selective language functions in subacute stroke.
We report a series of six single subject studies examining the effects of pharmacological blood pressure elevation on regional brain perfusion and language function. Previous reports indicate that hypoperfusion of specific brain regions, as delineated by magnetic resonance perfusion weighted imaging (PWI), is associated with disruption of selective lexical functions. On this basis, we hypothesized that reperfusion of the same regions, in the absence of infarct in that region, would restore the associated lexical function. We present five patients with impaired lexical-semantics associated with poor perfusion, but not infarction, of Brodmann's area 22 (BA 22), and one patient with impaired lexical-semantics and a superimposed deficit in retrieving the phonological representations of words, associated with poor perfusion Brodmann's area 37 (BA 37) as well as BA 22. Each patient was treated with induced blood pressure elevation to increase perfusion of the ischemic and dysfunctional tissue. Daily testing of naming and comprehension, with stimulus sets matched for frequency, familiarity, and length, showed improved lexical-semantics in the patients who showed reperfusion of BA 22 and improved oral naming (but not lexical-semantics) in the patient who showed reperfusion of BA 37. These cases illustrate that loss of function with hypoperfusion of a circumscribed area of the brain, and recovery of the same function with improved perfusion of that brain region, can reveal brain/language relationships prior to reorganization after brain injury.
Hillis
A E
AE
Department of Neurology, Johns Hopkins University School of Medicine, USA. argye@JHMI.edu
Kane
A
A
Tuffiash
E
E
Ulatowski
J A
JA
Barker
P B
PB
Beauchamp
N J
NJ
Wityk
R J
RJ
D000208:Acute Disease; D000316:Adrenergic alpha-Agonists / Q000494:pharmacology* / Q000627:therapeutic use*; D000368:Aged; D000369:Aged, 80 and over; D001794:Blood Pressure / Q000187:drug effects*; D001921:Brain / Q000098:blood supply* / Q000503:physiopathology*; D002560:Cerebrovascular Circulation / Q000502:physiology; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D010656:Phenylephrine / Q000494:pharmacology* / Q000627:therapeutic use*; D012660:Semantics; D013060:Speech / Q000502:physiology; D013067:Speech Perception / Q000502:physiology*; D020521:Stroke / Q000188:drug therapy / Q000503:physiopathology* / Q000628:therapy*; D014055:Tomography, Emission-Computed; D014825:Vocabulary
D000316:Adrenergic alpha-Agonists; D010656:Phenylephrine